120 related articles for article (PubMed ID: 15906355)
1. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis.
Bartel F; Schulz J; Böhnke A; Blümke K; Kappler M; Bache M; Schmidt H; Würl P; Taubert H; Hauptmann S
Int J Cancer; 2005 Nov; 117(3):469-75. PubMed ID: 15906355
[TBL] [Abstract][Full Text] [Related]
2. [HDMX amplification and high levels of HDMX-S splice variant are correlated with a poor prognosis in soft tissue sarcomas].
Bartel F; Schulz J; Blümke K; Kappler M; Bache M; Schmidt H; Taubert H
Verh Dtsch Ges Pathol; 2004; 88():199-206. PubMed ID: 16892553
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.
Bartel F; Meye A; Würl P; Kappler M; Bache M; Lautenschläger C; Grünbaum U; Schmidt H; Taubert H
Int J Cancer; 2001 May; 95(3):168-75. PubMed ID: 11307150
[TBL] [Abstract][Full Text] [Related]
4. Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
Lenos K; Grawenda AM; Lodder K; Kuijjer ML; Teunisse AF; Repapi E; Grochola LF; Bartel F; Hogendoorn PC; Wuerl P; Taubert H; Cleton-Jansen AM; Bond GL; Jochemsen AG
Cancer Res; 2012 Aug; 72(16):4074-84. PubMed ID: 22700878
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
[TBL] [Abstract][Full Text] [Related]
6. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
7. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
[TBL] [Abstract][Full Text] [Related]
8. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.
Taubert H; Koehler T; Meye A; Bartel F; Lautenschläger C; Borchert S; Bache M; Schmidt H; Würl P
Mol Med; 2000 Jan; 6(1):50-9. PubMed ID: 10803408
[TBL] [Abstract][Full Text] [Related]
9. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.
Taubert H; Schuster K; Brinck U; Bartel F; Kappler M; Lautenschläger C; Bache M; Trump C; Schmidt H; Holzhausen HJ; Würl P; Schlott T
Mod Pathol; 2003 Nov; 16(11):1109-16. PubMed ID: 14614050
[TBL] [Abstract][Full Text] [Related]
11. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract][Full Text] [Related]
12. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
[TBL] [Abstract][Full Text] [Related]
13. Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer.
Kriegmair MC; Balk M; Wirtz R; Steidler A; Weis CA; Breyer J; Hartmann A; Bolenz C; Erben P
Anticancer Res; 2016 Oct; 36(10):5205-5213. PubMed ID: 27798881
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma.
Sotobori T; Ueda T; Oji Y; Naka N; Araki N; Myoui A; Sugiyama H; Yoshikawa H
Cancer; 2006 May; 106(10):2233-40. PubMed ID: 16607650
[TBL] [Abstract][Full Text] [Related]
15. Identification and expression of a novel MDM4 splice variant in human glioma.
Wang X; Sheng P; Guo X; Wang J; Hou L; Hu G; Luo C; Dong Y; Lu Y
Brain Res; 2013 Nov; 1537():260-6. PubMed ID: 23994448
[TBL] [Abstract][Full Text] [Related]
16. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
Wynendaele J; Böhnke A; Leucci E; Nielsen SJ; Lambertz I; Hammer S; Sbrzesny N; Kubitza D; Wolf A; Gradhand E; Balschun K; Braicu I; Sehouli J; Darb-Esfahani S; Denkert C; Thomssen C; Hauptmann S; Lund A; Marine JC; Bartel F
Cancer Res; 2010 Dec; 70(23):9641-9. PubMed ID: 21084273
[TBL] [Abstract][Full Text] [Related]
17. HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea.
Jin G; Cook S; Cui B; Chen WC; Keir ST; Killela P; Di C; Payne CA; Gregory SG; McLendon R; Bigner DD; Yan H
Neuro Oncol; 2010 Sep; 12(9):956-66. PubMed ID: 20472715
[TBL] [Abstract][Full Text] [Related]
18. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.
Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M
BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890
[TBL] [Abstract][Full Text] [Related]
20. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
